gradient bar.png

Successfully Addressing Clinical Challenges in Worsening HF, ATTR Amyloidosis and HFpEF

On behalf of the Canadian Heart Failure Society, we are pleased to invite you to an upcoming CME program on The New HFrontier.

 

Select the event in your city to register.

​

HFrontier mountains.png
HFrontier mountains.png
HFrontier mountains.png

This event is an accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of
Physicians & Surgeons of Canada and approved by the Canadian Cardiovascular Society. You may claim a maximum of 2 hours.
The CHFS has received an educational grant from Bayer Inc., Alnylam and Pfizer for this initiative.

This program is made possible through an educational grant from Alnylam, Bayer Inc., and Pfizer

CHFS-SCIC_Logo.png